Guest guest Posted November 4, 2010 Report Posted November 4, 2010 from another list... A. Simpson, DC DABCOMedical Director, Vice PresidentThe CHP Group6600 SW 105th Ave, Suite 115Beaverton, ORĀ 97008503-619-2041 O503-367-0872 C503-644-0442 F Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?Hilda Bastian1*, Glasziou2, Iain Chalmers3http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000326 As for conflict of interest, I don't know how many of you in the Group have read the recent comprehensive research published by the US investigative journalism website ProPublica about big pharma and payment to US doctors for promoting their drugs to their colleagues; their findings are horrifying. One of my colleagues in North West England said after reading the articles 'this is the 21st century version of 19th century quackery': http://www.propublica.org/article/profiles-of-the-top-earners-in-dollar-for-docs http://www.propublica.org/blog/item/payments-to-doctors-by-most-pharma-companies-still-remain-secret http://www.propublica.org/article/how-the-drug-companies-say-they-screen-their-speaker-docs http://www.propublica.org/blog/item/doctors-on-pharma-payroll-what-our-partners-found http://projects.propublica.org/docdollars/ http://projects.propublica.org/docdollars/ http://www.propublica.org/article/lawsuits-say-pharma-illegally-paid-doctors-to-push-their-drugs http://www.propublica.org/article/dollars-to-doctors-physician-disciplinary-records http://www.propublica.org/article/how-patients-can-use-this-data http://www.propublica.org/article/consumer-reports-most-patients-worry-about-pharma-payments-to-doctors http://www.propublica.org/article/is-your-doctor-listed-in-dollars-for-docs Happy and depressing reading for those who wish to wade through all these 'must read' articles! Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.